Global Perspectives on Generics: International Policies and Practices
Global policies on generic drugs vary widely-from the U.S.'s high-volume, low-price model to China's aggressive bidding system and South Korea's precision pricing. These approaches save billions but risk quality and supply. Understanding how different countries balance affordability and reliability is key to sustainable healthcare.
